Ginkgo Bioworks Holdings, Inc. (DNA) vs Verastem, Inc. (VSTM)
Ginkgo Bioworks Holdings, Inc. and Verastem, Inc. are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and Verastem, Inc. are of similar size ($694.6M and $683.6M). Verastem, Inc. grew revenue faster over the last twelve months: 472.9% against −37.0%. Ginkgo Bioworks Holdings, Inc. has the higher net margin (−219.6% vs −231.6%) and the lower return on invested capital (−161.9% vs 0.00%). Across the 18 metrics below, Ginkgo Bioworks Holdings, Inc. leads on 11 and Verastem, Inc. on 7.
Valuation
Profitability
| Metric | DNA | VSTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 68.04% | 86.35% | 65.16% |
| Operating margin | (231.13%) | (182.57%) | 0.00% |
| Net margin | (219.60%) | (231.59%) | 0.00% |
| Free cash flow margin | (131.57%) | (185.31%) | 0.00% |
| Return on equity | (56.29%) | (471.16%) | (57.72%) |
| Return on assets | (26.19%) | (100.65%) | (49.22%) |
| Return on invested capital | (161.94%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack